Table 1.

Data on patients.

Patient No.	Sex	Age	Side	Length of time with disease (years)	UCLA before operation	Final UCLA	Seebauer classification	Pre-op OPE (Elev, Rext. Rint)	Post-op OPE (Elev, Rext. Rint)
1	F	80	D	4	(2+4+3+4+0) 13	(10+8+4+4+5) 31	IB	90;30;L1	120;40;S1
2	F	76	D	5	(2+2+1+4+0) 9	(8+6+2+5+5) 26	IB	40;20;L5	70;25;L2
3	M	82	D	6	(1+2+1+3+0) 7	(10+2+0+3+0) 15	IIA	30;10;S1	15;10;S1
4	F	75	D	3	(2+4+3+3+0) 12	(10+10+4+4+5) 33	IA	90;20;T12	130;30;T10
5	F	80	D	5	(2+2+1+3+0) 8	(10+6+2+4+5) 27	Ib	35;15;L5	60;20;L1
6	F	62	ND	6	(2+4+3+4+0) 13	(10+8+4+4+5) 31	IA	100;30;L1	120;40;L3
7	M	72	D	8	(2+2+2+3+0) 9	(8+6+3+3+5) 25	IIA	60;25;L5	90;30;L5
8	M	74	ND	4	(2+4+3+3+0) 12	(10+6+3+4+5) 28	IA	100;30;L1	90;40;L3
9	F	80	D	7	(2+2+2+4+0) 10	(10+6+2+4+5) 27	IIA	50;20;L3	60;20;L3
10	F	73	D	6	(2+4+3+4+0) 13	(10+6+3+4+5) 28	IB	90;20;T7	100;25;T12
11	F	70	D	4	(2+2+1+3+0) 8	(10+4+2+3+5) 24	IIA	30;10;S1	45;20;L5
12	F	84	D	7	(2+2+0+3+0) 7	(8+6+1+4+5) 24	IIA	20;10;TR0C	30;10;TR0C
13	F	67	D	6	(2+2+2+4+0) 10	(8+6+3+5+5) 27	Ib	70;30;L1	100;30;T12
14	F	73	ND	9	(2+4+1+4+0) 11	(8+6+1+5+5) 25	IIA	40;05;L5	30;10;S1
15	M	75	D	3	(2+4+3+4+0) 13	(10+6+3+4+5) 28	IB	100;30;L1	120;35;L1
16	F	73	ND	6	(2+4+2+3+0) 11	(8+8+3+4+5) 28	IIA	60;20;S1	100;40;L4
17	M	78	D	3	(2+2+1+4+0) 9	(8+6+1+5+5) 25	IB	30;10;S1	40;15;S1
18	F	80	D	8	(2+2+2+4+0) 10	(10+6+2+4+5) 27	IA	50;20;T10	70;35;L1
19	F	70	D	4	(2+4+3+4+0) 13	(10+6+3+4+5) 28	IA	120;30;L1	100;30;T12
20	F	67	ND	3	(2+2+0+4+0) 8	(8+6+1+5+5) 25	IIA	20;0;TR0C	40;10;S1
21	F	65	D	4	(2+4+3+4+0) 13	(10+6+3+4+5) 28	IB	90;40;T10	100;45;L1
22	F	71	D	6	(2+2+2+5+0) 11	(8+4+3+5+5) 25	IB	60;20;L5	100;30;L2
23	F	79	D	8	(2+2+1+4+0) 9	(10+4+2+4+5) 25	IIA	40;10;L5	60;10;S1

M = Male; F = Female; D = dominant limb; ND = non-dominant limb; EFO = orthopedic physical examination with range of motion; UCLA = University of California at Los Angeles – method for assessing postoperative results

Source: SAME IAMSPE / medical files